<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20250320225344&amp;utm_medium=rss&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20250320225344&amp;utm_medium=rss&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Fri, 21 Mar 2025 02:53:45 +0000</lastbuilddate>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Cardiac Patients in ICU Research: An Urgent Call for Inclusion</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40112166/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Acute Cardiovasc Care. 2025 Mar 20:zuaf042. doi: 10.1093/ehjacc/zuaf042. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40112166/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40112166</a> | DOI:<a href=https://doi.org/10.1093/ehjacc/zuaf042>10.1093/ehjacc/zuaf042</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40112166</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Steven M Hollenberg</dc:creator>
<dc:creator>Joseph E Parrillo</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Acute cardiovascular care</dc:source>
<dc:title>Cardiac Patients in ICU Research: An Urgent Call for Inclusion</dc:title>
<dc:identifier>pmid:40112166</dc:identifier>
<dc:identifier>doi:10.1093/ehjacc/zuaf042</dc:identifier>
</item>
<item>
<title>Predicting the diastolic left ventricular pressure curve non-invasively: How far can echo go?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40112160/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Cardiovasc Imaging. 2025 Mar 20:jeaf088. doi: 10.1093/ehjci/jeaf088. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40112160/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40112160</a> | DOI:<a href=https://doi.org/10.1093/ehjci/jeaf088>10.1093/ehjci/jeaf088</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40112160</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Frank A Flachskampf</dc:creator>
<dc:creator>James D Thomas</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Cardiovascular Imaging</dc:source>
<dc:title>Predicting the diastolic left ventricular pressure curve non-invasively: How far can echo go?</dc:title>
<dc:identifier>pmid:40112160</dc:identifier>
<dc:identifier>doi:10.1093/ehjci/jeaf088</dc:identifier>
</item>
<item>
<title>Better is possible: the fruits of a joint programme in cardiovascular imaging shared by radiologists and cardiologists</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40112028/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 20:ehae918. doi: 10.1093/eurheartj/ehae918. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40112028/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40112028</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae918>10.1093/eurheartj/ehae918</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40112028</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Marcelo F Di Carli</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Better is possible: the fruits of a joint programme in cardiovascular imaging shared by radiologists and cardiologists</dc:title>
<dc:identifier>pmid:40112028</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae918</dc:identifier>
</item>
<item>
<title>From data to perception: visualizing bias in artificial intelligence-generated images</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40111464/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 20:ehae850. doi: 10.1093/eurheartj/ehae850. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40111464/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40111464</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae850>10.1093/eurheartj/ehae850</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40111464</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Piotr Szymański</dc:creator>
<dc:creator>Magdalena Lipczyńska</dc:creator>
<dc:creator>Anna Maria Górska</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>From data to perception: visualizing bias in artificial intelligence-generated images</dc:title>
<dc:identifier>pmid:40111464</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae850</dc:identifier>
</item>
<item>
<title>Meet the team: new EHJ Editors Rosa Maria Bruno, Mattia Galli, and Mouaz Al-Mallah</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40111461/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Mar 20:ehae893. doi: 10.1093/eurheartj/ehae893. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40111461/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40111461</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae893>10.1093/eurheartj/ehae893</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40111461</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Judith Ozkan</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Meet the team: new EHJ Editors Rosa Maria Bruno, Mattia Galli, and Mouaz Al-Mallah</dc:title>
<dc:identifier>pmid:40111461</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae893</dc:identifier>
</item>
<item>
<title>Sex differences in cardiac remodelling in ischaemic cardiomyopathy and functional mitral regurgitation: impact on prognosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40110340/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: Because females with increasing LV size and FMR severity demonstrated significantly increased risk of adverse outcomes, our findings suggest the importance of deriving sex-specific CMR selection criteria for therapeutic management of FMR in the setting of ICM.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Imaging Methods Pract. 2025 Mar 19;3(1):qyaf021. doi: 10.1093/ehjimp/qyaf021. eCollection 2025 Jan.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Sex differences in prognosis of functional mitral regurgitation (FMR) associated with ischaemic cardiomyopathy (ICM) demonstrate the need to identify sex differences in cardiac remodelling. This study aimed to characterize sex differences in cardiac remodelling associated with FMR in the setting of ICM, sex interactions with cardiac remodelling and FMR severity, and predictors of all-cause mortality or heart transplantation using cardiac magnetic resonance (CMR) imaging.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: Consecutive patients with ICM referred to CMR between 2002 and 2017 were reviewed. Eligible 790 patients [mean age: 62.0 (standard deviation = 11.2] years and 24.7% females] were evaluated over a median follow-up of 5.8 years. There were 773 subjects with complete data for survival analysis, with 449 primary events. Coronary artery disease risk factors, medications, and previous coronary revascularization were similar in females and males (all <i>P</i> >; 0.05). Indexed left ventricular and right ventricular (LV and RV) volumes were larger in males (<i>P</i> &lt; or =0.005 for all comparisons) with similar slope of increasing LV and RV volumes in the setting of increasing FMR (all <i>P</i> >; 0.05, for interactions). However, indexed left atrial volume was similar in males and females (<i>P</i> = 0.696), after adjusting for FMR severity. After adjusting for medical risk factors and post-CMR procedural interventions, females demonstrated increased risk of primary clinical composite point with enlarging LV volumes [hazard ratio: 1.04 (95% confidence interval: 1.01-1.06), <i>P</i> = 0.034].</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Because females with increasing LV size and FMR severity demonstrated significantly increased risk of adverse outcomes, our findings suggest the importance of deriving sex-specific CMR selection criteria for therapeutic management of FMR in the setting of ICM.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40110340/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40110340</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11920871/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">PMC11920871</a> | DOI:<a href=https://doi.org/10.1093/ehjimp/qyaf021>10.1093/ehjimp/qyaf021</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40110340</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Duygu Kocyigit Burunkaya</dc:creator>
<dc:creator>Nancy A Obuchowski</dc:creator>
<dc:creator>Natalie Ho</dc:creator>
<dc:creator>Zoran B Popovic</dc:creator>
<dc:creator>David Chen</dc:creator>
<dc:creator>Christopher Nguyen</dc:creator>
<dc:creator>W H Wilson Tang</dc:creator>
<dc:creator>Deborah H Kwon</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Imaging methods and practice</dc:source>
<dc:title>Sex differences in cardiac remodelling in ischaemic cardiomyopathy and functional mitral regurgitation: impact on prognosis</dc:title>
<dc:identifier>pmid:40110340</dc:identifier>
<dc:identifier>pmc:PMC11920871</dc:identifier>
<dc:identifier>doi:10.1093/ehjimp/qyaf021</dc:identifier>
</item>
<item>
<title>Efficacy of an Internet of Things-based system for cardiac rehabilitation monitoring: insights from the IntellIoT pivotal trial in heart failure patients</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40110225/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: Internet of Things-based healthcare constitutes a promising approach in HF patients' rehabilitation, whereas elderly patients might constitute the population most likely to benefit. However, larger, randomized studies are required to confirm our findings.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Digit Health. 2024 Dec 19;6(2):293-297. doi: 10.1093/ehjdh/ztae093. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Digital health solutions targeted to remote clinical monitoring are constantly gaining ground in cardiovascular care. However, evidence regarding their impact on cardiac rehabilitation efficiency in heart failure (HF) patients is relatively limited. In this study, conducted in the context of the IntellIoT project, we evaluated the effect of a purpose-designed Internet of Things (IoT)-based patient monitoring system on cardiac rehabilitation outcomes in a cohort of HF patients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: Nineteen clinically stable HF patients were enrolled in the study, which consisted of a 12-month standard-of-care run-in phase and a remote follow-up phase of equal duration, whereby an IoT-based e-health system was provided to study subjects. Device-derived data transmission was facilitated by a mobile phone application, coupled with a web-based platform accessible to study physicians. Study endpoints were (i) patient adherence rates to e-health system use and their associations to key clinical parameters, (ii) the degree of change in physical activity, and (iii) total time dedicated by physicians to enrolled patients' care with and without the aid of the e-health system. Baseline-to-peak increase in daily step count was calculated at 23.34%. System use was associated with a decrease in time dedicated by physicians to enrolled patients' care. A significant negative correlation was observed between age and progressive drop-in adherence rate to system use (<i>r</i> = -0.5722, <i>P</i> = 0.02).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Internet of Things-based healthcare constitutes a promising approach in HF patients' rehabilitation, whereas elderly patients might constitute the population most likely to benefit. However, larger, randomized studies are required to confirm our findings.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40110225/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40110225</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914715/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">PMC11914715</a> | DOI:<a href=https://doi.org/10.1093/ehjdh/ztae093>10.1093/ehjdh/ztae093</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40110225</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Maria E Marketou</dc:creator>
<dc:creator>Ioannis Anastasiou</dc:creator>
<dc:creator>Alexis Fourlis</dc:creator>
<dc:creator>Aphrodite Alevizaki</dc:creator>
<dc:creator>George Kochiadakis</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Digital health</dc:source>
<dc:title>Efficacy of an Internet of Things-based system for cardiac rehabilitation monitoring: insights from the IntellIoT pivotal trial in heart failure patients</dc:title>
<dc:identifier>pmid:40110225</dc:identifier>
<dc:identifier>pmc:PMC11914715</dc:identifier>
<dc:identifier>doi:10.1093/ehjdh/ztae093</dc:identifier>
</item>
<item>
<title>Artificial intelligence for the analysis of intracoronary optical coherence tomography images: a systematic review</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40110224/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>Intracoronary optical coherence tomography (OCT) is a valuable tool for, among others, periprocedural guidance of percutaneous coronary revascularization and the assessment of stent failure. However, manual OCT image interpretation is challenging and time-consuming, which limits widespread clinical adoption. Automated analysis of OCT frames using artificial intelligence (AI) offers a potential solution. For example, AI can be employed for automated OCT image interpretation, plaque...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Digit Health. 2025 Jan 28;6(2):270-284. doi: 10.1093/ehjdh/ztaf005. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Intracoronary optical coherence tomography (OCT) is a valuable tool for, among others, periprocedural guidance of percutaneous coronary revascularization and the assessment of stent failure. However, manual OCT image interpretation is challenging and time-consuming, which limits widespread clinical adoption. Automated analysis of OCT frames using artificial intelligence (AI) offers a potential solution. For example, AI can be employed for automated OCT image interpretation, plaque quantification, and clinical event prediction. Many AI models for these purposes have been proposed in recent years. However, these models have not been systematically evaluated in terms of model characteristics, performances, and bias. We performed a systematic review of AI models developed for OCT analysis to evaluate the trends and performances, including a systematic evaluation of potential sources of bias in model development and evaluation.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40110224/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40110224</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914731/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">PMC11914731</a> | DOI:<a href=https://doi.org/10.1093/ehjdh/ztaf005>10.1093/ehjdh/ztaf005</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40110224</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Ruben G A van der Waerden</dc:creator>
<dc:creator>Rick H J A Volleberg</dc:creator>
<dc:creator>Thijs J Luttikholt</dc:creator>
<dc:creator>Pierandrea Cancian</dc:creator>
<dc:creator>Joske L van der Zande</dc:creator>
<dc:creator>Gregg W Stone</dc:creator>
<dc:creator>Niels R Holm</dc:creator>
<dc:creator>Elvin Kedhi</dc:creator>
<dc:creator>Javier Escaned</dc:creator>
<dc:creator>Dario Pellegrini</dc:creator>
<dc:creator>Giulio Guagliumi</dc:creator>
<dc:creator>Shamir R Mehta</dc:creator>
<dc:creator>Natalia Pinilla-Echeverri</dc:creator>
<dc:creator>Raúl Moreno</dc:creator>
<dc:creator>Lorenz Räber</dc:creator>
<dc:creator>Tomasz Roleder</dc:creator>
<dc:creator>Bram van Ginneken</dc:creator>
<dc:creator>Clara I Sánchez</dc:creator>
<dc:creator>Ivana Išgum</dc:creator>
<dc:creator>Niels van Royen</dc:creator>
<dc:creator>Jos Thannhauser</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Digital health</dc:source>
<dc:title>Artificial intelligence for the analysis of intracoronary optical coherence tomography images: a systematic review</dc:title>
<dc:identifier>pmid:40110224</dc:identifier>
<dc:identifier>pmc:PMC11914731</dc:identifier>
<dc:identifier>doi:10.1093/ehjdh/ztaf005</dc:identifier>
</item>
<item>
<title>Machine learning score to predict in-hospital outcomes in patients hospitalized in cardiac intensive care unit</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40110223/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: This new ML score is the first to demonstrate improved performance in predicting in-hospital outcomes over existing scores in patients admitted to the intensive care unit based on seven simple and rapid clinical and echocardiographic variables.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Digit Health. 2024 Dec 20;6(2):218-227. doi: 10.1093/ehjdh/ztae098. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Although some scores based on traditional statistical methods are available for risk stratification in patients hospitalized in cardiac intensive care units (CICUs), the interest of machine learning (ML) methods for risk stratification in this field is not well established. We aimed to build an ML model to predict in-hospital major adverse events (MAE) in patients hospitalized in CICU.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: In April 2021, a French national prospective multicentre study involving 39 centres included all consecutive patients admitted to CICU. The primary outcome was in-hospital MAE, including death, resuscitated cardiac arrest, or cardiogenic shock. Using 31 randomly assigned centres as an index cohort (divided into training and testing sets), several ML models were evaluated to predict in-hospital MAE. The eight remaining centres were used as an external validation cohort. Among 1499 consecutive patients included (aged 64 ± 15 years, 70% male), 67 had in-hospital MAE (4.3%). Out of 28 clinical, biological, ECG, and echocardiographic variables, seven were selected to predict MAE in the training set (<i>n</i> = 844). Boosted cost-sensitive C5.0 technique showed the best performance compared with other ML methods [receiver operating characteristic area under the curve (AUROC) = 0.90, precision-recall AUC = 0.57, <i>F</i>1 score = 0.5]. Our ML score showed a better performance than existing scores (AUROC: ML score = 0.90 vs. Thrombolysis In Myocardial Infarction (TIMI) score: 0.56, Global Registry of Acute Coronary Events (GRACE) score: 0.52, Acute Heart Failure (ACUTE-HF) score: 0.65; all <i>P</i> &lt; 0.05). Machine learning score also showed excellent performance in the external cohort (AUROC = 0.88).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: This new ML score is the first to demonstrate improved performance in predicting in-hospital outcomes over existing scores in patients admitted to the intensive care unit based on seven simple and rapid clinical and echocardiographic variables.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05063097.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40110223/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40110223</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914730/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">PMC11914730</a> | DOI:<a href=https://doi.org/10.1093/ehjdh/ztae098>10.1093/ehjdh/ztae098</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40110223</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Orianne Weizman</dc:creator>
<dc:creator>Kenza Hamzi</dc:creator>
<dc:creator>Patrick Henry</dc:creator>
<dc:creator>Guillaume Schurtz</dc:creator>
<dc:creator>Marie Hauguel-Moreau</dc:creator>
<dc:creator>Antonin Trimaille</dc:creator>
<dc:creator>Marc Bedossa</dc:creator>
<dc:creator>Jean Claude Dib</dc:creator>
<dc:creator>Sabir Attou</dc:creator>
<dc:creator>Tanissia Boukertouta</dc:creator>
<dc:creator>Franck Boccara</dc:creator>
<dc:creator>Thibaut Pommier</dc:creator>
<dc:creator>Pascal Lim</dc:creator>
<dc:creator>Thomas Bochaton</dc:creator>
<dc:creator>Damien Millischer</dc:creator>
<dc:creator>Benoit Merat</dc:creator>
<dc:creator>Fabien Picard</dc:creator>
<dc:creator>Nissim Grinberg</dc:creator>
<dc:creator>David Sulman</dc:creator>
<dc:creator>Bastien Pasdeloup</dc:creator>
<dc:creator>Yassine El Ouahidi</dc:creator>
<dc:creator>Treçy Gonçalves</dc:creator>
<dc:creator>Eric Vicaut</dc:creator>
<dc:creator>Jean-Guillaume Dillinger</dc:creator>
<dc:creator>Solenn Toupin</dc:creator>
<dc:creator>Théo Pezel</dc:creator>
<dc:creator>ADDICT-ICCU Investigators</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Digital health</dc:source>
<dc:title>Machine learning score to predict in-hospital outcomes in patients hospitalized in cardiac intensive care unit</dc:title>
<dc:identifier>pmid:40110223</dc:identifier>
<dc:identifier>pmc:PMC11914730</dc:identifier>
<dc:identifier>doi:10.1093/ehjdh/ztae098</dc:identifier>
</item>
<item>
<title>Multi-modal artificial intelligence algorithm for the prediction of left atrial low-voltage areas in atrial fibrillation patient based on sinus rhythm electrocardiogram and clinical characteristics: a retrospective, multicentre study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40110222/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: The multimodal AI algorithm, which integrated ECG images and clinical features, predicted the presence of LVAs with a higher degree of accuracy than ECG alone and the clinical LVA scores.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Digit Health. 2024 Dec 13;6(2):200-208. doi: 10.1093/ehjdh/ztae095. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: We aimed to develop an artificial intelligence (AI) algorithm capable of accurately predicting the presence of left atrial low-voltage areas (LVAs) based on sinus rhythm electrocardiograms (ECGs) in patients with atrial fibrillation (AF).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: The study included 1133 patients with AF who underwent catheter ablation procedures, with a total of 1787 12-lead ECG images analysed. Artificial intelligence-based algorithms were used to construct models for predicting the presence of LVAs. The DR-FLASH and APPLE clinical scores for LVAs prediction were calculated. A receiver operating characteristic (ROC) curve and a calibration curve were used to evaluate model performance. Multicentre validation included 92 AF patients from five centres, with a total of 174 ECGs. The data obtained from the participants were split into training (<i>n</i> = 906), validation (<i>n</i> = 113), and test sets (<i>n</i> = 114). Low-voltage areas were detected in 47.4% of all participants. Using ECG alone, the convolutional neural network (CNN) model achieved an area under the ROC curve (AUROC) of 0.704, outperforming both the DR-FLASH score (AUROC = 0.601) and the APPLE score (AUROC = 0.589). Two multimodal AI models, which integrated ECG images and clinical features, demonstrated higher diagnostic accuracy (AUROC 0.816 and 0.796 for the CNN-Multimodal and CNN-Random Forest-Multimodal models, respectively). Our models also performed well in the multicentre validation dataset (AUROC 0.711, 0.785, and 0.879 for the ECG alone, CNN-Multimodal, and CNN-Random Forest-Multimodal models, respectively).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: The multimodal AI algorithm, which integrated ECG images and clinical features, predicted the presence of LVAs with a higher degree of accuracy than ECG alone and the clinical LVA scores.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40110222/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40110222</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914728/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">PMC11914728</a> | DOI:<a href=https://doi.org/10.1093/ehjdh/ztae095>10.1093/ehjdh/ztae095</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40110222</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Yirao Tao</dc:creator>
<dc:creator>Deyun Zhang</dc:creator>
<dc:creator>Naidong Pang</dc:creator>
<dc:creator>Shijia Geng</dc:creator>
<dc:creator>Chen Tan</dc:creator>
<dc:creator>Ying Tian</dc:creator>
<dc:creator>Shenda Hong</dc:creator>
<dc:creator>XingPeng Liu</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Digital health</dc:source>
<dc:title>Multi-modal artificial intelligence algorithm for the prediction of left atrial low-voltage areas in atrial fibrillation patient based on sinus rhythm electrocardiogram and clinical characteristics: a retrospective, multicentre study</dc:title>
<dc:identifier>pmid:40110222</dc:identifier>
<dc:identifier>pmc:PMC11914728</dc:identifier>
<dc:identifier>doi:10.1093/ehjdh/ztae095</dc:identifier>
</item>
<item>
<title>A comparison of artificial intelligence-enhanced electrocardiography approaches for the prediction of time to mortality using electrocardiogram images</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40110221/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: Both the image 2D CNN and digitized 1D CNN enable mortality prediction from ECG images, with comparable performance to natively digital 1D CNN. Models trained on natively digital 1D ECGs can also be applied to digitized 1D ECGs, without any significant loss in performance. This work allows AI-ECG mortality prediction to be applied in diverse global settings lacking digital ECG infrastructure.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Digit Health. 2024 Nov 18;6(2):180-189. doi: 10.1093/ehjdh/ztae090. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Most artificial intelligence-enhanced electrocardiogram (AI-ECG) models used to predict adverse events including death require that the ECGs be stored digitally. However, the majority of clinical facilities worldwide store ECGs as images.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: A total of 1 163 401 ECGs (189 539 patients) from a secondary care data set were available as both natively digital traces and PDF images. A digitization pipeline extracted signals from PDFs. Separate 1D convolutional neural network (CNN) models were trained on natively digital or digitized ECGs, with a discrete-time survival loss function to predict <i>time to mortality</i>. A 2D CNN model was trained on 310 × 868 px ECG images. External validation was performed in 958 954 ECGs (645 373 patients) from a Brazilian primary care cohort and 1022 ECGs (1022 patients) from a Chagas disease cohort. The image 2D CNN model and digitized 1D CNN model performed comparably to natively digital 1D CNN model in internal [C-index 0.780 (0.779-0.781), 0.772 (0.771-0.774), and 0.775 (0.774-0.776), respectively] and external validation. Models trained on natively digital 1D ECGs had comparable performance when applied to digitized 1D ECGs [C-index 0.773 (0.771-0.774)].</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Both the image 2D CNN and digitized 1D CNN enable mortality prediction from ECG images, with comparable performance to natively digital 1D CNN. Models trained on natively digital 1D ECGs can also be applied to digitized 1D ECGs, without any significant loss in performance. This work allows AI-ECG mortality prediction to be applied in diverse global settings lacking digital ECG infrastructure.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40110221/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40110221</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914724/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">PMC11914724</a> | DOI:<a href=https://doi.org/10.1093/ehjdh/ztae090>10.1093/ehjdh/ztae090</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40110221</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Arunashis Sau</dc:creator>
<dc:creator>Boroumand Zeidaabadi</dc:creator>
<dc:creator>Konstantinos Patlatzoglou</dc:creator>
<dc:creator>Libor Pastika</dc:creator>
<dc:creator>Antônio H Ribeiro</dc:creator>
<dc:creator>Ester Sabino</dc:creator>
<dc:creator>Nicholas S Peters</dc:creator>
<dc:creator>Antonio Luiz P Ribeiro</dc:creator>
<dc:creator>Daniel B Kramer</dc:creator>
<dc:creator>Jonathan W Waks</dc:creator>
<dc:creator>Fu Siong Ng</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Digital health</dc:source>
<dc:title>A comparison of artificial intelligence-enhanced electrocardiography approaches for the prediction of time to mortality using electrocardiogram images</dc:title>
<dc:identifier>pmid:40110221</dc:identifier>
<dc:identifier>pmc:PMC11914724</dc:identifier>
<dc:identifier>doi:10.1093/ehjdh/ztae090</dc:identifier>
</item>
<item>
<title>Comparison of machine learning and conventional criteria in detecting left ventricular hypertrophy and prognosis with electrocardiography</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40110220/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: Artificial intelligence-based LVH diagnosis outperformed conventional ECG criteria and was a superior predictor of mortality compared to echocardiography-confirmed LVH.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Digit Health. 2025 Feb 11;6(2):252-260. doi: 10.1093/ehjdh/ztaf003. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Left ventricular hypertrophy (LVH) is clinically important; current electrocardiography (ECG) diagnostic criteria are inadequate for early detection. This study aimed to develop an artificial intelligence (AI)-based algorithm to improve the accuracy and prognostic value of ECG criteria for LVH detection.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: A total of 42 016 patients (64.3 ± 16.5 years, 55.3% male) were enrolled. LV mass index was calculated from echocardiographic measurements. Left ventricular hypertrophy screening utilized ECG criteria, including Sokolow-Lyon, Cornell product, Cornell/strain index, Framingham criterion, and Peguero-Lo Presti. An AI algorithm using CatBoost was developed and validated (training dataset 80% and testing dataset 20%). F1 scores, reflecting the harmonic mean of precision and recall, were calculated. Mortality data were obtained through linkage with the National Death Registry. The CatBoost-based AI algorithm outperformed conventional ECG criteria in detecting LVH, achieving superior sensitivity, specificity, positive predictive value, F1 score, and area under curve. Significant features to predict LVH involved QRS and P-wave morphology. During a median follow-up duration of 10.1 years, 1655 deaths occurred in the testing dataset. Cox regression analyses showed that LVH identified by AI algorithm (hazard ratio and 95% confidence interval: 1.587, 1.309-1.924), Sokolow-Lyon (1.19, 1.038-1.365), Cornell product (1.301, 1.124-1.505), Cornell/strain index (1.306, 1.185-1.439), Framingham criterion (1.174, 1.062-1.298), and echocardiography-confirmed LVH (1.124, 1.019-1.239) were all significantly associated with mortality. Notably, AI-diagnosed LVH was more predictive of mortality than echocardiography-confirmed LVH.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Artificial intelligence-based LVH diagnosis outperformed conventional ECG criteria and was a superior predictor of mortality compared to echocardiography-confirmed LVH.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40110220/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40110220</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914727/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">PMC11914727</a> | DOI:<a href=https://doi.org/10.1093/ehjdh/ztaf003>10.1093/ehjdh/ztaf003</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40110220</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Jui-Tzu Huang</dc:creator>
<dc:creator>Chih-Hsueh Tseng</dc:creator>
<dc:creator>Wei-Ming Huang</dc:creator>
<dc:creator>Wen-Chung Yu</dc:creator>
<dc:creator>Hao-Min Cheng</dc:creator>
<dc:creator>Hsi-Lu Chao</dc:creator>
<dc:creator>Chern-En Chiang</dc:creator>
<dc:creator>Chen-Huan Chen</dc:creator>
<dc:creator>Albert C Yang</dc:creator>
<dc:creator>Shih-Hsien Sung</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Digital health</dc:source>
<dc:title>Comparison of machine learning and conventional criteria in detecting left ventricular hypertrophy and prognosis with electrocardiography</dc:title>
<dc:identifier>pmid:40110220</dc:identifier>
<dc:identifier>pmc:PMC11914727</dc:identifier>
<dc:identifier>doi:10.1093/ehjdh/ztaf003</dc:identifier>
</item>
<item>
<title>Sudden cardiac arrest prediction via deep learning electrocardiogram analysis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40110219/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: Deep learning models processing ECG data are a promising means of screening for SCA, and this method explains differences in SCAs due to age and sex. Model performance improved when ECGs were nearer in time to SCAs, although ECG data up to a year prior had predictive value. Sudden cardiac arrest prediction was more dependent upon QRS complex data compared to other ECG segments.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Digit Health. 2025 Feb 25;6(2):170-179. doi: 10.1093/ehjdh/ztae088. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Sudden cardiac arrest (SCA) is a commonly fatal event that often occurs without prior indications. To improve outcomes and enable preventative strategies, the electrocardiogram (ECG) in conjunction with deep learning was explored as a potential screening tool.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: A publicly available data set containing 10 s of 12-lead ECGs from individuals who did and did not have an SCA, information about time from ECG to arrest, and age and sex was utilized for analysis to individually predict SCA or not using deep convolution neural network models. The base model that included age and sex, ECGs within 1 day prior to arrest, and data sampled from windows of 720 ms around the R-waves from 221 individuals with SCA and 1046 controls had an area under the receiver operating characteristic curve of 0.77. With sensitivity set at 95%, base model specificity was 31%, which is not clinically applicable. Gradient-weighted class activation mapping showed that the model mostly relied on the QRS complex to make predictions. However, models with ECGs recorded between 1 day to 1 month and 1 month to 1 year prior to arrest demonstrated predictive capabilities.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Deep learning models processing ECG data are a promising means of screening for SCA, and this method explains differences in SCAs due to age and sex. Model performance improved when ECGs were nearer in time to SCAs, although ECG data up to a year prior had predictive value. Sudden cardiac arrest prediction was more dependent upon QRS complex data compared to other ECG segments.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40110219/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40110219</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914729/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">PMC11914729</a> | DOI:<a href=https://doi.org/10.1093/ehjdh/ztae088>10.1093/ehjdh/ztae088</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40110219</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Matt T Oberdier</dc:creator>
<dc:creator>Luca Neri</dc:creator>
<dc:creator>Alessandro Orro</dc:creator>
<dc:creator>Richard T Carrick</dc:creator>
<dc:creator>Marco S Nobile</dc:creator>
<dc:creator>Sujai Jaipalli</dc:creator>
<dc:creator>Mariam Khan</dc:creator>
<dc:creator>Stefano Diciotti</dc:creator>
<dc:creator>Claudio Borghi</dc:creator>
<dc:creator>Henry R Halperin</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Digital health</dc:source>
<dc:title>Sudden cardiac arrest prediction via deep learning electrocardiogram analysis</dc:title>
<dc:identifier>pmid:40110219</dc:identifier>
<dc:identifier>pmc:PMC11914729</dc:identifier>
<dc:identifier>doi:10.1093/ehjdh/ztae088</dc:identifier>
</item>
<item>
<title>Interpretable predictive value of including HDL-2b and HDL-3 in an explainable boosting machine model for multiclass classification of coronary artery stenosis severity in acute myocardial infarction patients</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40110218/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: HDL-3 provides superior predictive value for evaluating coronary artery stenosis severity in AMI patients compared to HDL-2b and other conventional lipid markers.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Digit Health. 2024 Dec 23;6(2):228-239. doi: 10.1093/ehjdh/ztae100. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: The aim of this study was to use explainable boosting machine (EBM) to evaluate the predictive value of HDL-2b and HDL-3 levels in comparison with traditional lipid parameters in three-class classification of coronary artery stenosis severity in acute myocardial infarction (AMI) patients.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: In this cross-sectional study, 1200 AMI patients were evaluated. HDL subtypes were quantified via microfluidic chip detection, and stenosis severity was assessed via the Gensini scoring system. The Gensini scores were divided into three groups: low group (&lt;36.5), moderate group (36.5-72), and high group (>;72). Explainable boosting machine, an interpretable machine learning technique, was employed to assess the predictive value of HDL-2b and HDL-3 compared with traditional lipid markers. Explainable boosting machine was used as the main model in this study, whereas logistic regression, XGBoost, and Random Forest were selected as reference models for predictive performance. Model performance was evaluated using receiver operating characteristic curves. The HDL-3 (%) values were divided into three risk categories: low (>;43), moderate (30-43), and high (&lt;30). The incorporation of HDL-2b and HDL-3 levels into lipid profiling significantly increased the group importance scores. The macro-average area under the curve values for the four models were as follows: 0.56 for the logistic model, 0.54 for the EBM model, 0.50 for the Random Forest model, and 0.49 for the XGBoost model.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: HDL-3 provides superior predictive value for evaluating coronary artery stenosis severity in AMI patients compared to HDL-2b and other conventional lipid markers.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40110218/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40110218</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914717/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">PMC11914717</a> | DOI:<a href=https://doi.org/10.1093/ehjdh/ztae100>10.1093/ehjdh/ztae100</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40110218</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Bin Wang</dc:creator>
<dc:creator>Dong Li</dc:creator>
<dc:creator>Yu Geng</dc:creator>
<dc:creator>Feifei Jin</dc:creator>
<dc:creator>Yujie Wang</dc:creator>
<dc:creator>Changhua Lv</dc:creator>
<dc:creator>Tingting Lv</dc:creator>
<dc:creator>Yajun Xue</dc:creator>
<dc:creator>Ping Zhang</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Digital health</dc:source>
<dc:title>Interpretable predictive value of including HDL-2b and HDL-3 in an explainable boosting machine model for multiclass classification of coronary artery stenosis severity in acute myocardial infarction patients</dc:title>
<dc:identifier>pmid:40110218</dc:identifier>
<dc:identifier>pmc:PMC11914717</dc:identifier>
<dc:identifier>doi:10.1093/ehjdh/ztae100</dc:identifier>
</item>
<item>
<title>Machine learning-based scoring system to predict cardiogenic shock in acute coronary syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40110217/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: STOP SHOCK score is a simple ML-based tool available at first medical contact showing high performance for prediction of developing CS during hospitalization in ACS patients. The web application is available at https://stopshock.org/#calculator.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Digit Health. 2025 Jan 6;6(2):240-251. doi: 10.1093/ehjdh/ztaf002. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Cardiogenic shock (CS) is a severe complication of acute coronary syndrome (ACS) with mortality rates approaching 50%. The ability to identify high-risk patients prior to the development of CS may allow for pre-emptive measures to prevent the development of CS. The objective was to derive and externally validate a simple, machine learning (ML)-based scoring system using variables readily available at first medical contact to predict the risk of developing CS during hospitalization in patients with ACS.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: Observational multicentre study on ACS patients hospitalized at intensive care units. Derivation cohort included over 40 000 patients from Beth Israel Deaconess Medical Center, Boston, USA. Validation cohort included 5123 patients from the Sheba Medical Center, Ramat Gan, Israel. The final derivation cohort consisted of 3228 and the final validation cohort of 4904 ACS patients without CS at hospital admission. Development of CS was adjudicated manually based on the patients' reports. From nine ML models based on 13 variables (heart rate, respiratory rate, oxygen saturation, blood glucose level, systolic blood pressure, age, sex, shock index, heart rhythm, type of ACS, history of hypertension, congestive heart failure, and hypercholesterolaemia), logistic regression with elastic net regularization had the highest externally validated predictive performance (<i>c</i>-statistics: 0.844, 95% CI, 0.841-0.847).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: STOP SHOCK score is a simple ML-based tool available at first medical contact showing high performance for prediction of developing CS during hospitalization in ACS patients. The web application is available at https://stopshock.org/#calculator.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40110217/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40110217</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914733/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">PMC11914733</a> | DOI:<a href=https://doi.org/10.1093/ehjdh/ztaf002>10.1093/ehjdh/ztaf002</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40110217</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Allan Böhm</dc:creator>
<dc:creator>Amitai Segev</dc:creator>
<dc:creator>Nikola Jajcay</dc:creator>
<dc:creator>Konstantin A Krychtiuk</dc:creator>
<dc:creator>Guido Tavazzi</dc:creator>
<dc:creator>Michael Spartalis</dc:creator>
<dc:creator>Marta Kollarova</dc:creator>
<dc:creator>Imrich Berta</dc:creator>
<dc:creator>Jana Jankova</dc:creator>
<dc:creator>Frederico Guerra</dc:creator>
<dc:creator>Edita Pogran</dc:creator>
<dc:creator>Andrej Remak</dc:creator>
<dc:creator>Milana Jarakovic</dc:creator>
<dc:creator>Viera Sebenova Jerigova</dc:creator>
<dc:creator>Katarina Petrikova</dc:creator>
<dc:creator>Shlomi Matetzky</dc:creator>
<dc:creator>Carsten Skurk</dc:creator>
<dc:creator>Kurt Huber</dc:creator>
<dc:creator>Branislav Bezak</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Digital health</dc:source>
<dc:title>Machine learning-based scoring system to predict cardiogenic shock in acute coronary syndrome</dc:title>
<dc:identifier>pmid:40110217</dc:identifier>
<dc:identifier>pmc:PMC11914733</dc:identifier>
<dc:identifier>doi:10.1093/ehjdh/ztaf002</dc:identifier>
</item>
<item>
<title>Mobile/wearable digital devices for care of active cancer patients: a survey from the ESC Council of Cardio-Oncology</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40110216/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: Mobile/wearable digital devices are considered to play an important role in different settings of cardio-oncology, including monitoring of patients' parameters and arrhythmia detection. Their role in monitoring physical activity and QTc interval appears more nuanced. The most important perceived barrier to mobile/wearable digital device implementation is considered their high cost.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Digit Health. 2025 Jan 21;6(2):162-169. doi: 10.1093/ehjdh/ztae082. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: The Council of Cardio-Oncology of the European Society of Cardiology developed an on-line anonymous survey to provide an overall picture of the current practice on the use of mobile and wearable digital devices in cardio-oncology and the potential barriers to their large-scale applicability.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: Between June 2023 and January 2024, an online anonymous questionnaire was completed by 220 healthcare professionals from 55 countries. The greatest number of respondents reported that mobile/wearable digital devices have a role in all active cancer patients for measuring heart rate (33.9%), blood pressure (34.4%), body temperature (32.0%), physical activity (42.4%), and sleep (31.2%). In the setting of atrial fibrillation detection, respondents were evenly split between applying these technologies in all patients (33.0%) or only in selected patients (33.0%). Regarding QTc interval monitoring, 30.6% reported that mobile/wearable digital devices play a role only in selected patients. The decision to use the device was taken by the patient in 56.6% of cases and the physician in 43.4%. The most important barrier reported to mobile/wearable device implementation in the setting of cardiac rhythm monitoring and QTc measurement was their cost (weighted average: 3.38 and 3.39, respectively).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Mobile/wearable digital devices are considered to play an important role in different settings of cardio-oncology, including monitoring of patients' parameters and arrhythmia detection. Their role in monitoring physical activity and QTc interval appears more nuanced. The most important perceived barrier to mobile/wearable digital device implementation is considered their high cost.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40110216/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40110216</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914721/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">PMC11914721</a> | DOI:<a href=https://doi.org/10.1093/ehjdh/ztae082>10.1093/ehjdh/ztae082</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40110216</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Giuseppe Boriani</dc:creator>
<dc:creator>Jacopo F Imberti</dc:creator>
<dc:creator>Riccardo Asteggiano</dc:creator>
<dc:creator>Pietro Ameri</dc:creator>
<dc:creator>Davide A Mei</dc:creator>
<dc:creator>Michał Farkowski</dc:creator>
<dc:creator>Julian Chun</dc:creator>
<dc:creator>Josè Luis Merino</dc:creator>
<dc:creator>Teresa Lopez-Fernandez</dc:creator>
<dc:creator>Alexander R Lyon</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Digital health</dc:source>
<dc:title>Mobile/wearable digital devices for care of active cancer patients: a survey from the ESC Council of Cardio-Oncology</dc:title>
<dc:identifier>pmid:40110216</dc:identifier>
<dc:identifier>pmc:PMC11914721</dc:identifier>
<dc:identifier>doi:10.1093/ehjdh/ztae082</dc:identifier>
</item>
<item>
<title>Impact of a smartphone-connected remote monitoring system on self-management continuity and health awareness in cardiovascular outpatients: an exploratory survey</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40110215/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: This pilot study suggests that a smartphone-connected remote monitoring system may enhance self-management practices and health awareness among cardiovascular outpatients. While the findings are promising, larger studies with longer follow-up periods are needed to confirm these results and evaluate the system's impact on clinical outcomes.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Digit Health. 2024 Dec 24;6(2):289-292. doi: 10.1093/ehjdh/ztae101. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Cardiovascular diseases are a leading cause of death globally, and effective self-management is critical for patient outcomes. Integrating Internet of Things-enabled devices with smartphone applications presents a novel approach to enhancing self-management, yet challenges with digital literacy and device usability persist, especially among the elderly. This study aimed to evaluate the adherence, ease of use, and impact on health awareness of a smartphone-connected remote monitoring system among cardiovascular outpatients in Japan.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: We conducted a single-centre, prospective survey at Kumamoto University Hospital involving 10 cardiovascular outpatients (median age: 72.5 years) including heart failure (<i>n</i> = 2), hypertension (<i>n</i> = 3), post-cardiac surgery (<i>n</i> = 2), and others (<i>n</i> = 3). Participants received Bluetooth-enabled monitoring devices and a smartphone app for automatic data synchronization. Adherence, ease of use, and changes in health awareness were assessed through a structured questionnaire. The study found that 8 of 10 participants adhered to daily monitoring, with an average usage period of 48 days. Nine of 10 required minimal support with device use and 8 of 10 reported increase in health awareness. Seven of 10 indicated they could continue using it long term. The average recommendation score was 8.8/10. The timely detection of asymptomatic paroxysmal atrial fibrillation in one patient highlighted the system's potential clinical benefits.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: This pilot study suggests that a smartphone-connected remote monitoring system may enhance self-management practices and health awareness among cardiovascular outpatients. While the findings are promising, larger studies with longer follow-up periods are needed to confirm these results and evaluate the system's impact on clinical outcomes.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40110215/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40110215</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914722/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">PMC11914722</a> | DOI:<a href=https://doi.org/10.1093/ehjdh/ztae101>10.1093/ehjdh/ztae101</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40110215</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Masanobu Ishii</dc:creator>
<dc:creator>Masahiro Yamamoto</dc:creator>
<dc:creator>Yasuhiro Otsuka</dc:creator>
<dc:creator>So Ikebe</dc:creator>
<dc:creator>Yoshinori Yamanouchi</dc:creator>
<dc:creator>Kenichi Tsujita</dc:creator>
<dc:creator>Taishi Nakamura</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Digital health</dc:source>
<dc:title>Impact of a smartphone-connected remote monitoring system on self-management continuity and health awareness in cardiovascular outpatients: an exploratory survey</dc:title>
<dc:identifier>pmid:40110215</dc:identifier>
<dc:identifier>pmc:PMC11914722</dc:identifier>
<dc:identifier>doi:10.1093/ehjdh/ztae101</dc:identifier>
</item>
<item>
<title>An ensemble learning model for detection of pulmonary hypertension using electrocardiogram, chest X-ray, and brain natriuretic peptide</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40110214/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: Our ensemble learning model improved doctors' accuracy in detecting PH from ECG, CXR, and BNP examinations. This suggests that earlier and more accurate PH diagnosis is possible, potentially improving patient prognosis.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Digit Health. 2025 Jan 16;6(2):209-217. doi: 10.1093/ehjdh/ztae097. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Delayed diagnosis of pulmonary hypertension (PH) is a known cause of poor patient prognosis. We aimed to develop an artificial intelligence (AI) model, using ensemble learning method to detect PH using electrocardiography (ECG), chest X-ray (CXR), and brain natriuretic peptide (BNP), facilitating accurate detection and prompting further examinations.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: We developed a convolutional neural network model using ECG data to predict PH, labelled by ECG from seven institutions. Logistic regression was used for the BNP prediction model. We referenced a CXR deep learning model using ResNet18. Outputs from each of the three models were integrated into a three-layer fully connected multimodal model. Ten cardiologists participated in an interpretation test, detecting PH from patients' ECG, CXR, and BNP data both with and without the ensemble learning model. The area under the receiver operating characteristic curves of the ECG, CXR, BNP, and ensemble learning model were 0.818 [95% confidence interval (CI), 0.808-0.828], 0.823 (95% CI, 0.780-0.866), 0.724 (95% CI, 0.668-0.780), and 0.872 (95% CI, 0.829-0.915). Cardiologists' average accuracy rates were 65.0 ± 4.7% for test without AI model and 74.0 ± 2.7% for test with AI model, a statistically significant improvement (<i>P</i> &lt; 0.01).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Our ensemble learning model improved doctors' accuracy in detecting PH from ECG, CXR, and BNP examinations. This suggests that earlier and more accurate PH diagnosis is possible, potentially improving patient prognosis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40110214/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40110214</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914732/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">PMC11914732</a> | DOI:<a href=https://doi.org/10.1093/ehjdh/ztae097>10.1093/ehjdh/ztae097</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40110214</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Risa Kishikawa</dc:creator>
<dc:creator>Satoshi Kodera</dc:creator>
<dc:creator>Naoto Setoguchi</dc:creator>
<dc:creator>Kengo Tanabe</dc:creator>
<dc:creator>Shunichi Kushida</dc:creator>
<dc:creator>Mamoru Nanasato</dc:creator>
<dc:creator>Hisataka Maki</dc:creator>
<dc:creator>Hideo Fujita</dc:creator>
<dc:creator>Nahoko Kato</dc:creator>
<dc:creator>Hiroyuki Watanabe</dc:creator>
<dc:creator>Masao Takahashi</dc:creator>
<dc:creator>Naoko Sawada</dc:creator>
<dc:creator>Jiro Ando</dc:creator>
<dc:creator>Masataka Sato</dc:creator>
<dc:creator>Shinnosuke Sawano</dc:creator>
<dc:creator>Hiroki Shinohara</dc:creator>
<dc:creator>Koki Nakanishi</dc:creator>
<dc:creator>Shun Minatsuki</dc:creator>
<dc:creator>Junichi Ishida</dc:creator>
<dc:creator>Katsuhito Fujiu</dc:creator>
<dc:creator>Hiroshi Akazawa</dc:creator>
<dc:creator>Hiroyuki Morita</dc:creator>
<dc:creator>Norihiko Takeda</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Digital health</dc:source>
<dc:title>An ensemble learning model for detection of pulmonary hypertension using electrocardiogram, chest X-ray, and brain natriuretic peptide</dc:title>
<dc:identifier>pmid:40110214</dc:identifier>
<dc:identifier>pmc:PMC11914732</dc:identifier>
<dc:identifier>doi:10.1093/ehjdh/ztae097</dc:identifier>
</item>
<item>
<title>Personalized app-based coaching for improving physical activity in heart failure with preserved ejection fraction patients compared with standard care: rationale and design of the MyoMobile Study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40110212/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: Exercise intolerance is a primary symptom in HFpEF patients, leading to poor quality of life and HF-related adverse outcomes due to physical inactivity. The MyoMobile study was designed to investigate the use of app-based coaching to improve PA in patients with HFpEF with a personalized, home-based intervention, focusing on simple step counts for flexibility and ease of integration into daily routines.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Digit Health. 2025 Jan 30;6(2):298-309. doi: 10.1093/ehjdh/ztae096. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: Patients suffering from heart failure with preserved ejection fraction (HFpEF) often exhibit a sedentary lifestyle, contributing to the worsening of their condition. Although there is an inverse relationship between physical activity (PA) and adverse cardiovascular outcomes, the implementation of Class Ia PA guidelines is hindered by low participation in supervised and structured programmes, which are not suitable for a diverse population of HFpEF patients. The MyoMobile study has been designed to assess the effect of a 12-week, app-based coaching programme on promoting PA in patients with HFpEF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: The MyoMobile study was a single-centre, randomized, controlled three-armed parallel group clinical trial with prospective data collection to investigate the effect of a personalized mobile app health intervention compared with usual care on PA levels in patients with HFpEF. Major inclusion criteria were age ≥ 45 years, a diagnosis of HFpEF, LVEF >; 40%, and current HF symptoms (NYHA Class I-III). Major exclusion criteria included acute decompensated HF, non-ambulatory status, recent acute coronary syndrome or cardiac surgery, alternative diagnoses for HF symptoms, active cancer treatment, and physical or medical conditions affecting mobility. Participants were recruited from hospitals, general practices, and practices specialized in internal medicine and cardiology in the Rhine-Main area, Germany. Participants underwent an objective 7-day PA measurement with a 3D accelerometer (Dynaport, McRoberts) at screening and after the 12-week intervention period. Following the screening, eligible participants were randomized into one of three groups: standard care (PA consulting), the intervention arm with app-based PA tracking and coaching, or the intervention arm with tracking but without coaching. The primary efficacy endpoint was the change in average daily step count between the average step count at baseline and at the end of the intervention, comparing standard care to a 12-week app-based PA coaching intervention.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Exercise intolerance is a primary symptom in HFpEF patients, leading to poor quality of life and HF-related adverse outcomes due to physical inactivity. The MyoMobile study was designed to investigate the use of app-based coaching to improve PA in patients with HFpEF with a personalized, home-based intervention, focusing on simple step counts for flexibility and ease of integration into daily routines.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CLINICAL TRIAL REGISTRATION: URL: https://clinicaltrials.gov/ct2/show/NCT04940312.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">UNIQUE IDENTIFIER: NCT04940312.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40110212/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40110212</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914726/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">PMC11914726</a> | DOI:<a href=https://doi.org/10.1093/ehjdh/ztae096>10.1093/ehjdh/ztae096</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40110212</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Silav Zeid</dc:creator>
<dc:creator>Jürgen H Prochaska</dc:creator>
<dc:creator>Alexander Schuch</dc:creator>
<dc:creator>Sven Oliver Tröbs</dc:creator>
<dc:creator>Andreas Schulz</dc:creator>
<dc:creator>Thomas Münzel</dc:creator>
<dc:creator>Tanja Pies</dc:creator>
<dc:creator>Wilfried Dinh</dc:creator>
<dc:creator>Matthias Michal</dc:creator>
<dc:creator>Perikles Simon</dc:creator>
<dc:creator>Philipp Sebastian Wild</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Digital health</dc:source>
<dc:title>Personalized app-based coaching for improving physical activity in heart failure with preserved ejection fraction patients compared with standard care: rationale and design of the MyoMobile Study</dc:title>
<dc:identifier>pmid:40110212</dc:identifier>
<dc:identifier>pmc:PMC11914726</dc:identifier>
<dc:identifier>doi:10.1093/ehjdh/ztae096</dc:identifier>
</item>
<item>
<title>Supervised machine learning including environmental factors to predict in-hospital outcomes in acute heart failure patients</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40110211/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>CONCLUSION: Our ML model including in particular environmental variables exhibited a better performance than traditional statistical methods to predict in-hospital outcomes in patients admitted for AHF.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Digit Health. 2024 Dec 16;6(2):190-199. doi: 10.1093/ehjdh/ztae094. eCollection 2025 Mar.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIMS: While few traditional scores are available for risk stratification of patients hospitalized for acute heart failure (AHF), the potential benefit of machine learning (ML) is not well established. We aimed to assess the feasibility and accuracy of a supervised ML model including environmental factors to predict in-hospital major adverse events (MAEs) in patients hospitalized for AHF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS AND RESULTS: In April 2021, a French national prospective multicentre study included all consecutive patients hospitalized in intensive cardiac care unit. Patients admitted for AHF were included in the analyses. A ML model involving automated feature selection by least absolute shrinkage and selection operator (LASSO) and model building with a random forest (RF) algorithm was developed. The primary composite outcome was in-hospital MAE defined by death, resuscitated cardiac arrest, or cardiogenic shock requiring assistance. Among 459 patients included (age 68 ± 14 years, 68% male), 47 experienced in-hospital MAE (10.2%). Seven variables were selected by LASSO for predicting MAE in the training data set (<i>n</i> = 322): mean arterial pressure, ischaemic aetiology, sub-aortic velocity time integral, E/e', tricuspid annular plane systolic excursion, recreational drug use, and exhaled carbon monoxide level. The RF model showed the best performance compared with other evaluated models [area under the receiver operating curve (AUROC) = 0.82, 95% confidence interval (CI) (0.78-0.86); precision-recall area under the curve = 0.48, 95% CI (0.42-0.5), <i>F</i>1 score = 0.56). Our ML model exhibited a higher AUROC compared with an existing score for the prediction of MAE (AUROC for our ML model: 0.82 vs. ACUTE HF score: 0.57; <i>P</i> &lt; 0.001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSION: Our ML model including in particular environmental variables exhibited a better performance than traditional statistical methods to predict in-hospital outcomes in patients admitted for AHF.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">STUDY REGISTRATION: ClinicalTrials.gov identifier: NCT05063097.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40110211/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40110211</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914725/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">PMC11914725</a> | DOI:<a href=https://doi.org/10.1093/ehjdh/ztae094>10.1093/ehjdh/ztae094</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40110211</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Benjamin Sibilia</dc:creator>
<dc:creator>Solenn Toupin</dc:creator>
<dc:creator>Nabil Bouali</dc:creator>
<dc:creator>Jean-Baptiste Brette</dc:creator>
<dc:creator>Arthur Ramonatxo</dc:creator>
<dc:creator>Guillaume Schurtz</dc:creator>
<dc:creator>Kenza Hamzi</dc:creator>
<dc:creator>Antonin Trimaille</dc:creator>
<dc:creator>Emmanuel Gall</dc:creator>
<dc:creator>Nicolas Piliero</dc:creator>
<dc:creator>Alexandre Unger</dc:creator>
<dc:creator>Stéphane Andrieu</dc:creator>
<dc:creator>Trecy Gonçalves</dc:creator>
<dc:creator>Fabien Picard</dc:creator>
<dc:creator>Vincent Roule</dc:creator>
<dc:creator>François Roubille</dc:creator>
<dc:creator>Sonia Houssany-Pissot</dc:creator>
<dc:creator>Océane Bouchot</dc:creator>
<dc:creator>Victor Aboyans</dc:creator>
<dc:creator>Reza Rossanaly Vasram</dc:creator>
<dc:creator>Thomas Bochaton</dc:creator>
<dc:creator>Damien Logeart</dc:creator>
<dc:creator>Alain Cohen Solal</dc:creator>
<dc:creator>Jérôme Cartailler</dc:creator>
<dc:creator>Alexandre Mebazaa</dc:creator>
<dc:creator>Jean-Guillaume Dillinger</dc:creator>
<dc:creator>Patrick Henry</dc:creator>
<dc:creator>Théo Pezel</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Digital health</dc:source>
<dc:title>Supervised machine learning including environmental factors to predict in-hospital outcomes in acute heart failure patients</dc:title>
<dc:identifier>pmid:40110211</dc:identifier>
<dc:identifier>pmc:PMC11914725</dc:identifier>
<dc:identifier>doi:10.1093/ehjdh/ztae094</dc:identifier>
</item>
<item>
<title>From marginal gains to clinical utility: machine learning-based percutaneous coronary intervention risk prediction models</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40110210/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250320225344&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J Digit Health. 2025 Jan 16;6(2):159-161. doi: 10.1093/ehjdh/ztaf001. eCollection 2025 Mar.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40110210/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">40110210</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11914716/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250320225344&v=2.18.0.post9+e462414">PMC11914716</a> | DOI:<a href=https://doi.org/10.1093/ehjdh/ztaf001>10.1093/ehjdh/ztaf001</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40110210</guid>
<pubDate>Thu, 20 Mar 2025 06:00:00 -0400</pubDate>
<dc:creator>Muhammad Ibtsaam Qadir</dc:creator>
<dc:creator>Ravi S Hira</dc:creator>
<dc:creator>Fiona R Kolbinger</dc:creator>
<dc:date>2025-03-20</dc:date>
<dc:source>European heart journal. Digital health</dc:source>
<dc:title>From marginal gains to clinical utility: machine learning-based percutaneous coronary intervention risk prediction models</dc:title>
<dc:identifier>pmid:40110210</dc:identifier>
<dc:identifier>pmc:PMC11914716</dc:identifier>
<dc:identifier>doi:10.1093/ehjdh/ztaf001</dc:identifier>
</item>





























</channel>
</rss>